Coloplast stock sits 34.7 percent below its 52-week high
Published on 10/04/2026 at 10:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Coloplast stock (ISIN DK0060448595) was last at DKK 412.50 on Nasdaq Copenhagen on October 2, 2026 at 4:59 p.m. CEST, placing it 34.7 percent below its DKK 631.40 52-week high. On October 1, 2026, GlobeNewswire published a Coloplast major shareholder announcement linked to the companys planned generational change.
Q3 growth beats the estimate
The operating picture remains stronger than the share price suggests. Yahoo Finance reported Q3 FY26 organic growth of 6.6 percent against a 6.1 percent estimate, with revenue of DKK 7.36 billion and earnings of DKK 1.46 billion.
The comparison matters because Coloplasts latest quarter combined a revenue beat with a profit margin of 19.88 percent. Investors are therefore weighing demand resilience against execution and valuation concerns rather than growth alone.
Analysts see a divided valuation
The analyst picture is balanced. Investing.com lists 21 analysts, with 3 Buy, 15 Hold and 3 Sell ratings, producing a Neutral consensus and an average 12-month target of DKK 468.3. That target lies 13.5 percent above the DKK 412.50 reference price, while the published high and low targets are DKK 625 and DKK 377.
The most direct negative counterpoint came on September 9, 2026, when MarketScreener reported that JPMorgan cut Coloplast to Underweight and set a DKK 377 price target. The gap between that target and the consensus average captures the stocks central debate: durable organic growth versus execution risk.
Next earnings date is November 3
Coloplasts market capitalization stood at DKK 92.9 billion on October 2, 2026, while the stock traded within a DKK 410.60 to DKK 415.30 daily range. MarketScreener lists November 3, 2026 as the annual 2026 earnings release date, giving investors the next scheduled checkpoint for guidance and margins.
Coloplast stock snapshot
- Company: Coloplast A/S
- ISIN: DK0060448595
- Ticker: COLO B
- Trading venue: Nasdaq Copenhagen
- Price as of October 2, 2026, 4:59 p.m. CEST: DKK 412.50, last at
- Market capitalization: DKK 92.9 billion (as of October 2, 2026)
- 52-week range: DKK 369.70-631.40 (as of October 2, 2026)
- Sector / Industry: Healthcare / Medical Equipment, Supplies and Distribution
- Next earnings date: November 3, 2026
Upcoming dates for Coloplast stock
- November 3, 2026: Annual 2026 earnings release
